GLTO
Price
$29.49
Change
+$0.41 (+1.41%)
Updated
Dec 24 closing price
Capitalization
47.04M
Intraday BUY SELL Signals
LSBCF
Price
$0.84
Change
-$0.00 (-0.00%)
Updated
Dec 24 closing price
Capitalization
34.62M
Intraday BUY SELL Signals
Interact to see
Advertisement

GLTO vs LSBCF

Header iconGLTO vs LSBCF Comparison
Open Charts GLTO vs LSBCFBanner chart's image
Galecto
Price$29.49
Change+$0.41 (+1.41%)
Volume$18.1K
Capitalization47.04M
LakeShore Biopharma
Price$0.84
Change-$0.00 (-0.00%)
Volume$146
Capitalization34.62M
GLTO vs LSBCF Comparison Chart in %
GLTO
Daily Signal:
Gain/Loss:
LSBCF
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
GLTO vs. LSBCF commentary
Dec 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLTO is a Hold and LSBCF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 26, 2025
Stock price -- (GLTO: $29.49 vs. LSBCF: $0.84)
Brand notoriety: GLTO and LSBCF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GLTO: 1% vs. LSBCF: 3%
Market capitalization -- GLTO: $47.04M vs. LSBCF: $34.62M
GLTO [@Biotechnology] is valued at $47.04M. LSBCF’s [@Biotechnology] market capitalization is $34.62M. The market cap for tickers in the [@Biotechnology] industry ranges from $117.47B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GLTO’s FA Score shows that 0 FA rating(s) are green whileLSBCF’s FA Score has 1 green FA rating(s).

  • GLTO’s FA Score: 0 green, 5 red.
  • LSBCF’s FA Score: 1 green, 4 red.
According to our system of comparison, GLTO is a better buy in the long-term than LSBCF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GLTO’s TA Score shows that 3 TA indicator(s) are bullish while LSBCF’s TA Score has 1 bullish TA indicator(s).

  • GLTO’s TA Score: 3 bullish, 5 bearish.
  • LSBCF’s TA Score: 1 bullish, 5 bearish.
According to our system of comparison, GLTO is a better buy in the short-term than LSBCF.

Price Growth

GLTO (@Biotechnology) experienced а +12.00% price change this week, while LSBCF (@Biotechnology) price change was -0.44% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.88%. For the same industry, the average monthly price growth was +4.46%, and the average quarterly price growth was +55.39%.

Industries' Descriptions

@Biotechnology (+2.88% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GLTO($47M) has a higher market cap than LSBCF($34.6M). GLTO YTD gains are higher at: 534.194 vs. LSBCF (-75.723).
GLTOLSBCFGLTO / LSBCF
Capitalization47M34.6M136%
EBITDA-16.28MN/A-
Gain YTD534.194-75.723-705%
P/E RatioN/AN/A-
Revenue0N/A-
Total Cash7.61MN/A-
Total Debt72KN/A-
TECHNICAL ANALYSIS
Technical Analysis
GLTOLSBCF
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
40%
Momentum
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
54%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
57%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
73%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
52%
Advances
ODDS (%)
Bullish Trend 2 days ago
80%
N/A
Declines
ODDS (%)
Bearish Trend 8 days ago
88%
Bearish Trend 15 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
74%
Aroon
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
GLTO
Daily Signal:
Gain/Loss:
LSBCF
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TIAIY7.22N/A
N/A
Telecom Italia S.p.A.
CAPFF1.55N/A
N/A
Capital Limited
CLZNF8.86N/A
N/A
Clariant AG
MTLK0.36N/A
N/A
Metalink Ltd.
TOEYF0.28N/A
-0.21%
Toro Energy Ltd.

GLTO and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLTO has been loosely correlated with COGT. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if GLTO jumps, then COGT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLTO
1D Price
Change %
GLTO100%
+1.41%
COGT - GLTO
44%
Loosely correlated
-1.10%
VIVS - GLTO
38%
Loosely correlated
+7.22%
KZR - GLTO
34%
Loosely correlated
+0.16%
SYRE - GLTO
34%
Loosely correlated
-0.54%
KPTI - GLTO
33%
Poorly correlated
+0.40%
More

LSBCF and

Correlation & Price change

A.I.dvisor indicates that over the last year, LSBCF has been loosely correlated with STTK. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if LSBCF jumps, then STTK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LSBCF
1D Price
Change %
LSBCF100%
N/A
STTK - LSBCF
38%
Loosely correlated
+3.47%
BCTX - LSBCF
30%
Poorly correlated
+7.15%
GLTO - LSBCF
27%
Poorly correlated
+1.41%
PROK - LSBCF
26%
Poorly correlated
+2.80%
LGVN - LSBCF
22%
Poorly correlated
-1.59%
More